Wearable activity tracking for hormone-positive metastatic breast cancer
Part of Cancer, Skin clinical trials.
This study tests whether using a wearable watch and smartphone app to track activity and fitness can help monitor health in people with hormone receptor–positive, HER2-negative metastatic breast cancer while they take standard hormone therapy plus palbociclib. It mainly requires that you are already on these medicines for at least three months and can use the devices reliably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older with hormone receptor–positive, HER2-negative metastatic breast cancer
- You are currently taking palbociclib plus hormone treatment (an aromatase inhibitor or fulvestrant), and the plan fits the study lines of therapy
- You have been on palbociclib and the hormone medicine for at least 3 months
- You can sign informed consent and agree not to join another drug study while in this study
- You have a compatible smartphone and reliable 3G or 4G internet to use the app
- Your overall health is stable enough to safely join (not a very high-risk medical situation), and you expect to live at least 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether wearing a smartwatch and using an app can help doctors better manage pain and other symptoms in advanced cancer patients. The goal is to catch problems early and improve comfort through better symptom tracking.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This trial studies how using a wearable device and smartphone app can help monitor your health during your first cancer treatment for advanced solid tumors. You will receive a known therapy (not a placebo), and the research team will collect real-world data to improve care.
This study looks at how your daily step count, measured by a smartwatch, relates to how well your breast cancer responds to treatment before surgery. It may help show if being more active during chemotherapy leads to better outcomes.
This trial tests if a wearable device paired with a smartphone app can help monitor symptoms in cancer survivors. The goal is to improve how we track and manage symptoms during and after treatment.
This study uses a smartwatch to track your physical activity and see if it helps reduce tiredness after finishing chemotherapy. It is for people who finished treatment for certain cancers less than 3 months ago.
Hear when a new Breast Neoplasm Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.